NCT02938949View on ClinicalTrials.gov

Alirocumab in Patients With Acute Myocardial Infarction

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 31, 2018

Study Completion Date

August 16, 2018

Conditions

Myocardial InfarctionHypercholesterolemia

Interventions

DRUG

alirocumab

DRUG

placebo

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

Virginia Commonwealth University

OTHER